The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study.
% of type I diabetics are not administering insulin according to the intensified conventional therapy schedules, only 16.8% of all type II diabetics are treated with diet only. Type II diabetics are much too often treated with pre-mixed insulins of too high dosage (26.2%) or with oral hypoglycemics (46.2%) of which 90% were sulphonylureas and nearly exclusively glibenclamide. Oral hypoglycemics with extrapancreatic activity or combined therapies were not common among the patients.
AdultC-PeptideCardiovascular DiseasesCreatinineDiabetes ComplicationsDiabetes MellitusEmploymentFemaleGermanyGlycated Hemoglobin AGovernment AgenciesHumansHypoglycemic AgentsInpatientsInsurance, HealthLipidsMaleMiddle AgedSerum Albumin
Research Support, Non-U.S. Gov't